National Comprehensive Cancer Network

Subscriptions & Products
For Patients

About NCCN

Ovarian Cancer Panel - Disclosures as of 9/2/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Ronald D. Alvarez, MD

Morphotek Inc.

Eli Lilly and Company;
GlaxoSmithKline;
Ortho Biotech Products, L.P.

None

None

7/22/2010

Deborah K. Armstrong, MD

Morphotek Inc.;
Agensys/Astella

Abraxis Bioscience, Inc.;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
Morphotek Inc.

None

None

4/6/2010

Barry Boston, MD

BEST

Bayer HealthCare;
Onyx Pharmaceuticals, Inc.;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

10/28/2009

Robert Burger, MD, FACOG, FACS

       

Pending

Lee-may Chen, MD

AstraZeneca Pharmaceuticals LP

None

None

None

7/6/2009

Larry Copeland, MD

Eli Lilly and Company;
Genentech, Inc.;
Gynecologic Oncology Group

Bayer HealthCare;
Celgene Corporation;
Eli Lilly and Company;
Precision Therapeutics, Inc.;
sanofi-aventis U.S.

None

Gynecologic Oncology Group

10/2/2009

Marta Ann Crispens, MD

None

None

None

None

10/13/2009

Mary Dwyer, MS

None

None

None

None

7/15/2010

Lauren Gallagher, RPh, PhD

None

None

None

None

8/23/2010

David M Gershenson, MD

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Johnson & Johnson;
National Cancer Institute

National Cancer Institute

Abbott Laboratories;
Amgen Inc.;
Eli Lilly and Company;
Johnson & Johnson;
Elsevier

None

9/28/2009

Heidi J. Gray, MD

       

Pending

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

8/30/2010

Perry W. Grigsby, MD, MS, MBA

None

None

None

None

7/1/2009

Ardeshir Hakam, MD

       

Pending

Laura J. Havrilesky, MD

None

BD-TriPath Oncology;
Precision Therapeutics, Inc.

None

None

10/6/2009

Miranda Hughes, PhD

None

None

Myriad Genetic Laboratories, Inc.;
Affymetrix;
Qiagen NV

None

7/15/2010

Carolyn Johnston, MD

None

None

None

american cancer society-great lakes division;
michigan cancer consortium

7/8/2009

Shashikant Lele, MD

None

None

None

None

8/21/2009

Ursula A. Matulonis, MD

AstraZeneca Pharmaceuticals LP;
Eli Lilly and Company;
Genentech, Inc.;
Merck & Co., Inc.

Eisai Inc.;
Merck & Co., Inc.

None

None

10/9/2009

Joan S. McClure, MS

None

None

None

None

7/18/2010

Robert J. Morgan, MD, FACP

NIH-CTEP

None

Abbott Laboratories

None

5/18/2010

David M. O'Malley, MD

Genentech, Inc.

KCI

None

None

5/12/2010

Richard T. Penson, MD, MRCP

Berlex Inc.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
CuraGen Corporation;
Dara BioSciences, Inc.;
Endocyte Inc.;
PDL BioPharma, Inc.

None

None

None

11/24/2009

Steven W. Remmenga, MD

None

None

None

None

7/20/2010

Paul Sabbatini, MD

None

Boehringer Ingelheim GmbH;
Genentech, Inc.;
Johnson & Johnson

None

None

9/1/2009

Russell J. Schilder, MD

None

None

None

None

7/2/2009

Julian C Schink, MD

None

None

None

None

9/28/2009

Nelson Teng, MD, PhD

GOG

None

None

None

1/15/2010

Theresa L. Werner, MD

None

None

None

Myriad Pharma

4/22/2010

 

NCCN Website Supporters